With reference to the earlier announcement regarding holding the Meeting of Board Company on May 25, 2013, inter alia, for transacting the following business:
1. To approve the un-audited financial results of the Company for the Quarter Ended March 31, 2013.
2. To approve the resignation of Mr. Anil Kumar Khadke as Nominee Director of Central Bank of India w.e.f. March 15, 2013,
Ankur Drugs and Pharma Ltd has now informed BSE that due to non availability of the Chairman & Managing Director as also the Executive Director on the date of the Board Meeting, it has been decided to postpone the same to a future date.
Disclaimer: यह कंटेंट सिर्फ़ जानकारी के लिए है और इसे निवेश सलाह या रेकमेंडेशन नहीं मानना चाहिए.
शिकायतों के लिए संपर्क करें: [email protected]